Previous 10 | Next 10 |
The first and only monthly Water Gradient multifocal contact lens — feels like nothing even at day 30 1 Provides excellent visual acuity at all distances, near through far, with Alcon’s proven Precision Profile design that fits in two easy steps, delivering 96% fit s...
2023-09-26 08:21:30 ET Summary The Cooper Companies, which focuses on vision products and medical devices, has seen a decline in profits and cash flows recently. Despite revenue growth, higher costs and expenses have put pressure on the company's bottom line. Shares of The Coo...
2023-09-25 16:23:00 ET Summary The Cooper Companies' silicone hydrogel daily contact lens business has driven significant market share growth and still has above-average growth potential. Cooper's myopia management business could become a $1 billion market, and the company has a f...
Alcon Vivity Registry continues to demonstrate excellent outcomes with AcrySof IQ Vivity and AcrySof IQ Vivity Toric, the first and only PCIOL + with wavefront-shaping technology World-renowned surgeons will present new registry data at #ESCRS2023, including data on rates of visual di...
2023-09-08 08:45:53 ET Palm Beach, FL – September 8, 2023 – FinancialNewsMedia.com News Commentary – The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome (DES) or Dry E...
Alcon innovations featured in more than 75 abstracts across cataract, refractive, visualization and ocular health 1 Clinical data presentations and sponsored symposia to highlight the efficacy of Alcon’s intraocular lens and surgical equipment portfolio Booth activation...
2023-09-05 01:20:00 ET Summary Lifecore Biomedical has divested its food-related assets and now focuses solely on its high-quality CDMO business. The company faced a rough patch earlier this year but has since refinanced its debt, secured a major customer contract, and is on the v...
2023-09-04 12:21:00 ET Needham sees the medtech sector growing by 7% in 2023 versus 5.7% last year, despite slowed growth in Q2, helped by double-digit growth in certain cardiology categories. The investment bank noted that medtech growth slowed slightly in Q2, expanding by only 8.3% co...
Alcon Inc. (NYSE: ALC) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 2.4% on the day to $82.17. Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for ey...
2023-08-17 11:18:38 ET More on Alcon Alcon Inc. ( ALC ) Q2 2023 Earnings Call Transcript Alcon: Lackluster Growth Given Its Valuation Alcon: The Steady Force Of 'Boring' Alcon Non-GAAP EPS of $0.69 beats by $0.04, revenue of $2.4B beats by $20M Al...
News, Short Squeeze, Breakout and More Instantly...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Alcon Inc. (NYSE: ALC) traded at a new 52-week high today and are currently trading at $91.69. So far today, approximately 136.09k shares have been exchanged, as compared to an average 30-day volume of 907.93k shares. Alcon Inc., an eye care company, researches, develops, manufactur...